Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 01, 2008 (Vol. 28, No. 3)

DNA Methylation Bolsters Cancer Research

Technique Will Play an Important Role in Diagnostics, Arrays, and Therapeutics

  • Globally, the epigenomics market is estimated to reach $4.1 billion by 2012, up from $263.2 million in 2006, according to a March 2007 report by BCC Research. The key market segments include research tools, cancer diagnostics, and cancer therapeutics. Many companies are focused on developing specific molecules or assays ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.